| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |